On November 3, 2021 Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, reported that it will be virtually participating in two upcoming investor conferences (Press release, Akoya Biosciences, NOV 3, 2021, View Sourcenews-releases/news-release-details/akoya-participate-two-upcoming-investor-conferences-november" target="_blank" title="View Sourcenews-releases/news-release-details/akoya-participate-two-upcoming-investor-conferences-november" rel="nofollow">View Source [SID1234594261]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum: Nov. 18

Panel: The Next Revolution in Biology: A Deep Dive into the Past, Present & Future of Spatial Biology – Brian McKelligon, Chief Executive Officer, will participate in a panel on Thursday, November 18th at 1:00 p.m. ET. Interested parties may access a live webcast of the event via the "Investors" section of the Akoya website at View Source and will be available for 90 days thereafter.

Piper Sandler 33rd Annual Virtual Healthcare Conference: Nov. 30 – Dec. 2

Fireside Chat – Brian McKelligon, Chief Executive Officer, and Joe Driscoll, Chief Financial Officer, will participate in a fireside chat, which will be available beginning Monday, November 22, 2021, at 10:00 a.m. ET on Akoya’s investor relations website at View Source.